Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

Staging of hepatocellular carcinoma (HCC) is necessary for guiding prognostication,
management, and research purposes that further aid in the improvement of existing clinical …

Hepatocellular carcinoma is one of the most frequent malignant tumors worldwide: Portal
vein tumor thrombosis (PVTT) occurs in about 35%-50% of patients and represents a strong …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Purpose To evaluate a fully automated machine learning algorithm that uses pretherapeutic
quantitative CT image features and clinical factors to predict hepatocellular carcinoma …

Simple Summary Individual patients with liver cancer have a highly variable clinical course.
Hence, there is an urgent need to identify new prognostic markers to determine prognosis …

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related
deaths worldwide with rapidly growing incidence rates in the USA and Europe. Despite …